Expanding clinical trials into the EU and UK creates new opportunities for sponsors but also brings complex data protection and legal requirements.

Under the EU Clinical Trials Regulation (CTR), sponsors without an EU establishment must appoint a clinical trial legal representative as part of the submission process. The same obligation applies to EU medical device and in vitro diagnostic device (IVD) performance studies conducted under the Medical Device Regulation (MDR) and In Vitro Device Regulation (IVDR).

In addition, organisations are typically required to appoint a Data Protection Representative (DPR) under the GDPR, with comparable requirements under UK clinical trial and data protection laws.

While both a legal representative and DPR are essential, they serve distinct purposes and are frequently misunderstood or treated as interchangeable.

Join experts from The DPO Centre and DLRC Group to understand how to remove friction from your application process and ensure both your legal and data protection framework is right first time. Hear directly from specialists with extensive experience advising sponsors across multi-jurisdictional trials.

Watch On Demand

June 16, 2026

EU & UK CLINICAL TRIALS: Are you clear on your data protection and legal representation requirements?

Expanding clinical trials into the EU and UK creates new opportunities for sponsors but also brings complex data protection and legal requirements. Under the EU Clinical Trials Regulation (CTR), sponsors without an EU establishment must appoint a clinical trial legal representative as part […]
April 14, 2026

NOT A CURE-ALL: Is tokenisation the solution for data sharing?

Clinical research teams are under increased pressure to get more value from trial data. It needs to be shared responsibly, reused where appropriate, and stored in […]
February 24, 2026

FULLY ASSURED: Getting privacy and assurance right in clinical trials

For clinical research and healthcare organisations, assurance is now a business-critical issue. Sponsors, CROs and trial partners are increasingly expected to evidence how privacy, security, and […]
November 27, 2025

DOUBLE BLIND: Secondary use of health data and AI in clinical trials

The secondary use of health data is becoming one of the biggest drivers of innovation across clinical research. But as AI technology advances and EU and […]
October 21, 2025

STRICTLY CONFIDENTIAL: Reducing risk in Healthcare DSAR responses

Data Subject Access Requests (DSARs) in the Healthcare sector present unique challenges due to the sensitive nature of patient information. Responding to these requests requires not […]
October 15, 2024

FIRST, DO NO HARM: Safeguarding clinical trials from data breaches and legal challenges

Data breaches are an increasing risk for the healthcare industry, including clinical trials. Our Life Sciences Sector Lead and senior legal specialist, Joanne Elieli, discuss common […]
Change your cookie consent